Establishment Labs Holdings Inc. (ESTA) Stock Analysis

Company Overview

Establishment Labs Holdings Inc. (ESTA) is capitalised at $2.21B on the latest close. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 1,004 employees.

Over the past 52 weeks the price has ranged from $36.53 to $97.59. ESTA last closed at $74.29 on September 4, 2026. That is +$1.99 (+2.75%) against the previous close. The latest close sits 103.37% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $211.08M. Against the prior fiscal year total of $166.03M, that is a change of +27.14%. The same year closed with a net loss of $51.06M. The reported profit margin is −15.82%. That is 14.1 percentage points below the Medical Devices median of −1.69%. Trailing earnings per share are −1.27.

Across the 4 fiscal years on file, revenue moves from $161.70M in 2022 to $211.08M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. On forward earnings the ratio is 1,238.17. Measured against sales, the shares trade at 9.01 times revenue. On price-to-sales that is 3 times the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 1.05. Annualized volatility over the trailing 8 years is 66.79%. The trailing one-year price return is +92.11%. Measured over 5 years, that is −0.10% a year compounded.

Growth & Income

The record shows no dividend for ESTA.

2026 is still running; the price is +1.93% year to date. The strongest complete calendar year on file is 2021 at +79.57%; the weakest is 2023 at −60.56%. Of the 7 complete calendar years on file, 5 finished higher.